Crossmark Global Holdings Inc. Acquires 49,600 Shares of Envista Holdings Corporation $NVST

Crossmark Global Holdings Inc. raised its holdings in shares of Envista Holdings Corporation (NYSE:NVST) by 423.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 61,320 shares of the company’s stock after buying an additional 49,600 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Envista were worth $1,249,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Ariel Investments LLC boosted its position in shares of Envista by 1.7% during the 2nd quarter. Ariel Investments LLC now owns 12,355,666 shares of the company’s stock valued at $241,430,000 after acquiring an additional 210,921 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Envista by 4.0% in the third quarter. Dimensional Fund Advisors LP now owns 9,537,874 shares of the company’s stock worth $194,284,000 after purchasing an additional 367,363 shares during the last quarter. Franklin Resources Inc. raised its stake in Envista by 16.7% in the second quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock valued at $175,011,000 after purchasing an additional 1,284,767 shares in the last quarter. Alliancebernstein L.P. raised its stake in Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares in the last quarter. Finally, Clarkston Capital Partners LLC lifted its position in Envista by 0.4% during the second quarter. Clarkston Capital Partners LLC now owns 4,703,330 shares of the company’s stock valued at $91,903,000 after purchasing an additional 16,583 shares during the last quarter.

Envista Trading Down 0.7%

Shares of NVST opened at $26.68 on Tuesday. Envista Holdings Corporation has a fifty-two week low of $14.22 and a fifty-two week high of $30.42. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of 95.30, a PEG ratio of 1.83 and a beta of 0.95. The firm has a 50 day moving average price of $25.89 and a 200-day moving average price of $22.48. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38.

Envista (NYSE:NVST) last released its earnings results on Thursday, February 5th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. The business’s revenue was up 15.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts forecast that Envista Holdings Corporation will post 1 earnings per share for the current year.

Insider Activity

In other news, SVP Mischa Reis sold 9,675 shares of Envista stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares in the company, valued at approximately $971,460. The trade was a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.66% of the company’s stock.

Analyst Ratings Changes

NVST has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. UBS Group lifted their price objective on shares of Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, February 3rd. Piper Sandler reissued a “neutral” rating and issued a $25.00 target price (up from $21.00) on shares of Envista in a research note on Friday, February 6th. William Blair upgraded Envista from a “hold” rating to an “outperform” rating in a research report on Friday, February 6th. Finally, Leerink Partners set a $35.00 price target on Envista and gave the stock an “outperform” rating in a research note on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $27.75.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.